publication venue for
- Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. 2022
- EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.. 9. 2024
- CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation.. 9. 2024
- Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.. 7. 2022
- Central role of myeloid MCPIP1 in protecting against LPS-induced inflammation and lung injury.. 2. 2017
- Platelets prime hematopoietic and vascular niche to drive angiocrine-mediated liver regeneration.. 2. 2017
- Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization. 2023
- Epigenetic regulation of cancer stemness. 2025
- Targeting fibrosis, mechanisms and cilinical trials. 2022